Study of Effects of YisuiShengxueGranules on Thalassemia
Status:
Completed
Trial end date:
2012-01-01
Target enrollment:
Participant gender:
Summary
The primary objectives of this study are to evaluate whether Yisui Shengxue Granules therapy
can increase the hemoglobin level in peripheral blood and alleviate the symptoms, and at the
same time, evaluate its safety in the treatment of Thalassemia with the syndrome of
deficiency of liver-yin and kidney-yin, and asthenia of essence and blood.
Details
Lead Sponsor:
Guang'anmen Hospital of China Academy of Chinese Medical Sciences